Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit
January 02, 2025 15:17 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Caribou Biosciences, Inc. (CRBU) Misled Investors Regarding the Efficacy of its Lead Drug Candidate